Extrait

Background and study aims The main aim of this study is to assess the effectiveness of Family Therapy (FT) compared to Treatment as Usual (TAU) for adolescents aged 11-17 years who have engaged in at least one previous episode of self-harm, as measured by rates of repetition of self-harm leading to hospital attendance over an 18-month period. Who can participate? The study aimed to recruit 832 families (adolescents aged 11-17 years who have engaged in at least one previous episode of self-harm, and their parent/guardian) over a 3-year period from Child and Adolescent Mental Health Services (CAMHS) in Yorkshire, Greater Manchester and London. What does the study involve? Families who consented to participate in the trial were randomly allocated to either TAU (standard care offered by local CAHMS team) or FT (delivered by trial-specific Family Therapists). If allocated to FT, families were requested to attend about eight FT sessions over a 6-month period depending on individual requirements. All families were then followed-up at 3, 6, 12 and 18 months to complete questionnaires and assessments. What are the possible benefits and risks of participating? The trial team do not anticipate any addition risks in taking part in this trial. Although the trial team hope that families completing family therapy will find the treatment useful we can't say that this treatment will definitely help. The same would be true for families not taking part in the trial. The main benefit is that the research project will help us learn more about how to help people who have self-harmed in the future. Where is the study run from? The study is being led by a team of researchers at the University of Leeds, in collaboration with researchers at the University of Manchester and Kings College London. When is the study starting and how long is it expected to run for? The first family was recruited to the trial in April 2010. The trial closed to recruitment in December 2013 (44 months), having recruited the full sample required for statistical analysis. The trial is now in the follow-up phase ahead of final analysis with trial results anticipated by early 2016. Who is funding the study? NIHR Health Technology Assessment Programme - HTA (UK). Who is the main contact? Chief Investigator - Professor David Cottrell, University of Leeds ([email protected]) Senior Trial Manager - Ms Liz Graham, University of Leeds ([email protected])

Critère d'inclusion

• Self-harm in adolescents

Liens

• ictrp
• isrctn